Zora Nešković‐Konstantinović
- Oncology top 10%
- HER2/EGFR in Cancer Research 18
- Cancer Treatment and Pharmacology 7
-
- Breast Cancer Treatment Studies 7
-
- Retinoids in leukemia and cellular processes 5
- TGF-β signaling in diseases 5
-
- Estrogen and related hormone effects 15
- Chronic Lymphocytic Leukemia Research 3
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Dragica Nikolić‐VukosavljevićNataša Todorović‐RakovićKsenija KanjerVesna IvanovićMiroslav DemajoVesna SubotaAnna BerkenblitSnežana Bošnjak
- Journals
- The International Journal of Biological Markers (3 papers)Redox Report (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- SerbiaUnited StatesBelgium
In The Last Decade
Zora Nešković‐Konstantinović
46 papers receiving 681 citations
Peers
Comparison fields: 5 of 79
- Oncology 419
- Cancer Research 144
- Pulmonary and Respiratory Medicine 220
- Molecular Biology 338
- Genetics 123
Countries citing papers authored by Zora Nešković‐Konstantinović
This map shows the geographic impact of Zora Nešković‐Konstantinović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zora Nešković‐Konstantinović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zora Nešković‐Konstantinović more than expected).
Fields of papers citing papers by Zora Nešković‐Konstantinović
This network shows the impact of papers produced by Zora Nešković‐Konstantinović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zora Nešković‐Konstantinović. The network helps show where Zora Nešković‐Konstantinović may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zora Nešković‐Konstantinović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 13 | |
| 2 | 2013 | 7 | |
| 3 | 2012 | 222 | |
| 4 | 2012 | 15 | |
| 5 | 2009 | 7 | |
| 6 | 2009 | 4 | |
| 7 | 2008 | 1 | |
| 8 | 2007 | 15 | |
| 9 | 2007 | 15 | |
| 10 | 2005 | 17 | |
| 11 | 2005 | 16 | |
| 12 | Effects of X-ray irradiation on the overexpression of HER-2/Erb-B2 on breast cancer cell lines. | 2004 | 3 |
| 13 | 2003 | 108 | |
| 14 | PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression. | 2001 | 2 |
| 15 | 2000 | 7 | |
| 16 | Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease. | 1999 | 15 |
| 17 | 1996 | 21 | |
| 18 | 1996 | 7 | |
| 19 | 1994 | 9 | |
| 20 | 1992 | 14 |
About Zora Nešković‐Konstantinović
Zora Nešković‐Konstantinović is a scholar working on Oncology, Cancer Research and Genetics, having authored 49 papers that have together received 698 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Estrogen and related hormone effects (15 papers), Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Retinoids in leukemia and cellular processes (5 papers), TGF-β signaling in diseases (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (419 citations), Cancer Research (144 citations) and Pulmonary and Respiratory Medicine (220 citations). Zora Nešković‐Konstantinović has collaborated with scholars based in Serbia, United States and Belgium. Frequent co-authors include Dragica Nikolić‐Vukosavljević, Nataša Todorović‐Raković, Ksenija Kanjer, Vesna Ivanović, Miroslav Demajo, Vesna Subota, Anna Berkenblit, Snežana Bošnjak, Antonio C. Wolff and Yan Sun. Their work appears in journals such as The International Journal of Biological Markers, Redox Report, European Journal of Cancer, Journal of Chemotherapy and Clinical and Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.